Lurie Cancer Center and Northwestern Medicine Experts Present at #ASH23

Physicians and scientists from the Robert H. Lurie Comprehensive Cancer Center of Northwestern University and Northwestern Medicine will present and discuss exciting new research and important clinical findings at the American Society of Hematology (ASH) Annual Meeting, December 9-12 in San Diego, California. With more than 18,000 members from nearly 100 countries, ASH is the world’s largest professional society serving both clinicians and scientists around the world who are working to conquer blood diseases.

Follow @LurieCancer and use #ASH23 to follow and share on Twitter.

Presenting authors and investigators who will be leading sessions at #ASH23 include the following. View the full 2023 ASH Annual Meeting Schedule.

Friday, December 8
Scientific Workshop on Germline Predisposition to Hematopoietic Malignancies and Bone Marrow Failure Program Co-chair: Lucy Godley, MD, PhD 2:00 p.m. - 5:00 p.m. \| Room 29 (San Diego Convention Center)
Saturday, December 9
Immune Reconstitution and Infection Patterns Following CAR T-Cell Therapy in Patients with Aggressive Lymphoma Abstract No. 1738 Poster Presenter: Megan Melody, MD, MS 5:30 p.m. – 7:30 p.m. \| Halls G-H (San Diego Convention Center)
Exploration of Language As a Barrier to the Assessment and Management of CAR T-Cell Therapy Associated Toxicities Abstract No. 2407 Poster Presenter: Megan Melody, MD, MS 5:30 p.m. – 7:30 p.m. \| Halls G-H (San Diego Convention Center)
Aggressive Lymphomas: Clinical and Epidemiological: Poster I Abstract No. 627 Poster Presenter: Megan Melody, MD, MS 5:30 p.m. – 7:30 p.m. \| Halls G-H (San Diego Convention Center)
Sunday, December 10
Aggressive Lymphomas: Prospective Therapeutic Trials: Novel Therapies For Relapsed/Refractory Aggressive Lymphoma Abstract No. 626 Moderator: Reem Karmali, MD 9:30 a.m. – 11:00 a.m. \| Seaport Ballroom ABCD (Manchester Grand Hyatt San Diego)
Bone Marrow Failure: Acquired: Unraveling the Future of PNH Therapy From Clinical Trials Abstract No. 508 Moderator: Jamile Shammo, MD 4:30 PM-6:00 PM \| Room 7 (San Diego Convention Center)
Photoablation with the Aurolase System Reduces T Cell Exhaustion and Synergizes with Immunotherapies in Lymphoma Abstract No. 2825 Poster Presenter: Adam Yuh Lin, MD, PhD 6:00 p.m. – 8:00 p.m \| San Diego Convention Center, Halls G-H
Characteristics and Outcomes of Younger Adult Patients (Pts) with Myelodysplastic Syndromes (MDS): A Multicenter Retrospective Study Abstract No. 3232 Poster Presenter: Yasmin Abaza, MD 6:00 p.m. – 8:00 p.m \| San Diego Convention Center, Halls G-H
Rapid Degradation of mDia2 Protein during Terminal Erythropoiesis Via an In Vivo Aid System: An Alternative Approach for Loss-of-Function Studies Abstract No. 2443 Poster Presenter: Kehan Ren 6:00 p.m. – 8:00 p.m \| San Diego Convention Center, Halls G-H
Monday, December 11
Naturally Occurring Mutations in Human T Cell Lymphomas Enhance Engineered T Cell Therapies Abstract No. 884 Presenter: Jay Daniels 3:00 p.m.
Acute Myeloid Leukemias: Commercially Available Therapies, Excluding Transplantation and Cellular Immunotherapies: Improving Intensive Chemotherapy Regimens for Treatment of AML Abstract No. 615 Moderator: Jessica Altman, MD 4:30 p.m. – 6:00 p.m. \| San Diego Ballroom AB (Marriott Marquis San Diego Marina)
DDX41 Dissolves G-Quadruplexes to Maintain Erythroid Genomic Integrity and Prevent Genome DNA Leakage-Induced Cgas Activation Abstract No. 949 Presenter: Honghao Bi, PhD 4:30 p.m.
A Phase Ib Study to Evaluate the Safety and Efficacy of Nivolumab in Combination with R-CHOP in High-Risk DLBCL Abstract No. 4462 Poster Presenter: Oluwatobi Odetola, MD 6:00 p.m. – 8:00 p.m. \| San Diego Convention Center, Halls G-H

NOTE: Presenter information is sometimes incomplete. If your session is missing, please email the link to cancer@northwestern.edu.

Lurie Cancer Center and Northwestern Medicine Experts Present at #ASH23

Friday, December 8

Saturday, December 9

Sunday, December 10

Monday, December 11